Q1 2024 scPharmaceuticals Inc Earnings Call
Despite a net loss and increased operational costs, scPharmaceuticals Inc (SCPH) reports significant progress in product development and market expansion.
scPharmaceuticals (SCPH) delivered earnings and revenue surprises of 20% and 6.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?